The size of the North American Clinical Nutrition market was worth USD 4.79 Billion in 2023 and is estimated to be growing at a CAGR of 4.76% to reach USD 6.04 Billion by 2028.
The increasing prevalence of metabolic diseases across the North American region majorly drives the growth of the clinical nutrition market in North America. Common metabolic disorders include liver diseases, obesity, diabetes, cardiovascular disease, and kidney issues. In the United States, approximately one in three adults have metabolic syndrome. Lifestyle changes, unhealthy food consumption, tobacco usage, low physical activity, and alcohol consumption are major contributing factors to metabolic issues among the population. Clinical nutrition is crucial in understanding the relationship between ingested food and overall body health. It focuses on preventing, diagnosing, and managing nutritional changes associated with chronic diseases and infections in healthcare. Moreover, clinical nutrition helps maintain a healthy energy balance and gives patients essential nutrients like protein, minerals, and vitamins.
The growing healthcare expenditure and rising focus on a healthy lifestyle among the population of North American countries further contribute to the North American market growth. Many individuals seek the expertise of clinical nutrition specialists to assess their nutrient levels and receive prescriptions for daily nutrition to support their overall health. Clinical nutrition plays a crucial role in managing chronic diseases like diabetes, heart disease and cancer while also promoting healthy weight management through improved food choices.
The growing investments in research and development, rising support from healthcare organizations and increasing government backing propel the growth of the clinical nutrition market in North America. The surge in novel diseases and infections among the population supports the North American market growth. Manufacturers are actively focusing on developing oral nutrients with various flavors to propel market growth further.
The lack of awareness about clinical nutrition, a scarcity of skilled professionals, inadequate infrastructure facilities and limited availability of clinical products are some of the major factors hampering the growth of the North American clinical nutrition market on the other hand.
This research report on the North American clinical nutrition market has been segmented and sub-segmented into the following categories:
By Product Type:
By Therapeutic Areas:
By Ingredients Type:
North America accounted for the largest share of the worldwide clinical nutrition market in 2022 and is anticipated to continue the dominating trend throughout the forecast period owing to advancements in the healthcare sector and growing awareness about clinical nutrition among the population. The increasing number of athletes in North American region contributes to market growth, as clinical nutrition optimizes their performance and aids in post-exercise recovery, while also reducing the risk of injuries. Moreover, clinical nutrition is increasingly adopted by infants, pregnant, and breastfeeding women to ensure a balanced diet and provide necessary nutrients for the growth of the fetus and infants, addressing genetic and health issues.
The U.S. is estimated to capture the major share of the North American market during the forecast period. The presence of numerous manufacturing facilities, the growing availability of clinical nutrition products in the U.S., an increasing number of courses focused on clinical nutrition, the presence of pharmaceutical and nutrition companies and the establishment of universities majorly contribute to the clinical nutrition market growth in the U.S.
Canada accounted for a notable share of the North American market in 2022 and is expected to grow at a prominent CAGR in the coming years owing to the growing number of clinical nutrition programs offered by healthcare organizations and nutritionists. The rise in adult and pediatric clinical nutrition centers and the surge in mergers and acquisitions in Canada propels the Canadian market growth.
KEY MARKET PLAYERS:
Companies playing a dominant role in the North American clinical nutrition market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
The North American clinical nutrition market is expected to be valued at USD 4.79 billion in 2023.
Some key trends include the increasing adoption of personalized nutrition solutions, the rise in demand for clinical nutrition in athletes and fitness enthusiasts, and the integration of advanced technologies in nutrition products.
The pandemic has increased the demand for clinical nutrition products, especially those focused on immune support and overall health, as consumers seek to strengthen their immunity.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com